BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9517518)

  • 1. Hepatobiliary changes in patients with ulcerative colitis, with special reference to the effect of proctocolectomy.
    Aitola P; Matikainen M; Mattila J
    Scand J Gastroenterol; 1998 Feb; 33(2):113-7. PubMed ID: 9517518
    [No Abstract]   [Full Text] [Related]  

  • 2. [Should liver biopsy be systematic during surgery for ulcerative colitis?].
    Scalone O; Bonaventure C; Pasquier D; Faucheron JL
    Gastroenterol Clin Biol; 2003 Jan; 27(1):94-9. PubMed ID: 12594372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of proctocolectomy on serum antineutrophil cytoplasmic antibodies in patients with chronic ulcerative colitis.
    Aitola P; Miettinen A; Mattila A; Matikainen M; Soppi E
    J Clin Pathol; 1995 Jul; 48(7):645-7. PubMed ID: 7560172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in the liver of patients with chronic ulcerohemorrhagic colitis].
    Nikolovska D; Dzhadzhova-Boneva M; Bakalov V; Kadiian Kh
    Vutr Boles; 1988; 27(4):6-9. PubMed ID: 3062895
    [No Abstract]   [Full Text] [Related]  

  • 5. [Primary sclerosing cholangitis--an ulcerative colitis-associated illness with surgical consequences].
    Heuschen G; Heuschen UA; Herfarth C
    Chirurg; 1998 Oct; 69(10):1028-34. PubMed ID: 9833181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proctocolectomy for ulcerative colitis after liver transplantation for primary sclerosing cholangitis.
    Bosso MC; Marchesa PE; Ricchiuti A; Giacardi A; Cocchis D; Campi M; Palisi M; Salizzoni M
    Transplant Proc; 2009 May; 41(4):1390-2. PubMed ID: 19460568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of primary sclerosing cholangitis in ulcerative colitis patients undergoing proctocolectomy and ileal pouch-anal anastomosis.
    Lepistö A; Kärkkäinen P; Järvinen HJ
    Inflamm Bowel Dis; 2008 Jun; 14(6):775-9. PubMed ID: 18253951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of dysplasia and adenocarcinoma following restorative proctocolectomy for ulcerative colitis.
    Walker M; Radley S
    Colorectal Dis; 2007 Nov; 9(9):856. PubMed ID: 17931176
    [No Abstract]   [Full Text] [Related]  

  • 9. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis.
    Duerr RH; Targan SR; Landers CJ; LaRusso NF; Lindsay KL; Wiesner RH; Shanahan F
    Gastroenterology; 1991 May; 100(5 Pt 1):1385-91. PubMed ID: 2013383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restorative proctocolectomy and ileal pouch-anal anastomosis for ulcerative colitis after liver transplant for primary sclerosing cholangitis: case report and review of literature.
    Grucela AL; Steinhagen RM
    Am Surg; 2005 Apr; 71(4):362-5. PubMed ID: 15943415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ulcerative colitis and primary sclerosing cholangitis--does proctocolectomy have a therapeutic effect?].
    Dirks E; Singer MV
    Z Gastroenterol; 1990 Apr; 28(4):222-4. PubMed ID: 2399752
    [No Abstract]   [Full Text] [Related]  

  • 12. Restorative proctocolectomy and pouch anal anastomosis for ulcerative colitis following orthotopic liver transplantation.
    Rowley S; Candinas D; Mayer AD; Buckels JA; McMaster P; Keighley MR
    Gut; 1995 Dec; 37(6):845-7. PubMed ID: 8537060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver involvement and its course in patients operated on for ulcerative colitis.
    Mikkola K; Kiviluoto T; Riihelä M; Taavitsainen M; Järvinen HJ
    Hepatogastroenterology; 1995 Feb; 42(1):68-72. PubMed ID: 7782040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver lesions found at colectomy in ulcerative colitis: correlation between histological findings and biochemical parameters.
    Mattila J; Aitola P; Matikainen M
    J Clin Pathol; 1994 Nov; 47(11):1019-21. PubMed ID: 7829676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.
    Seibold F; Weber P; Klein R; Berg PA; Wiedmann KH
    Gut; 1992 May; 33(5):657-62. PubMed ID: 1612483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases. High prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis.
    Hardarson S; Labrecque DR; Mitros FA; Neil GA; Goeken JA
    Am J Clin Pathol; 1993 Mar; 99(3):277-81. PubMed ID: 8447289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunogenetic basis for anti-neutrophil cytoplasmic antibody production in primary sclerosing cholangitis and ulcerative colitis.
    Mehal WZ; Lo SK; Chapman RW; Fleming KA
    J Hepatol; 1994 Nov; 21(5):910-1. PubMed ID: 7890911
    [No Abstract]   [Full Text] [Related]  

  • 18. The enigma of anti-neutrophil antibodies in ulcerative colitis primary sclerosing cholangitis: important genetic marker or epiphenomenon?
    Chapman RW
    Hepatology; 1995 May; 21(5):1473-4. PubMed ID: 7737656
    [No Abstract]   [Full Text] [Related]  

  • 19. Restorative proctocolectomy and primary sclerosing cholangitis: an acceptable pairing?
    Heise CP
    Dis Colon Rectum; 2011 Jul; 54(7):771-2. PubMed ID: 21654241
    [No Abstract]   [Full Text] [Related]  

  • 20. Alopecia areata, primary sclerosing cholangitis, and ulcerative colitis: autoimmunity and apoptosis as common links?
    Katsinelos P; Kountouras J; Paroutoglou G; Zavos C
    Dig Dis Sci; 2007 May; 52(5):1288-92. PubMed ID: 17372831
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.